Health care law business Frier Levitt has analyzed FDA enforcement steps versus “analysis only” peptide distributors. Their summary: the FDA considers an item’s classification determined by its supposed use, not its disclaimers. When Web sites consist of dosage guides, reconstitution Guidance, or ur